The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Long term hold and rewards will be in a few years. This year is going to be a transformational year for the company with what is in the pipeline, it's not even started yet.
Now that's good news and profit.
I put a few quid into MGC for products and trails they are doing on epilepsy, cancer and covid etc. Very interesting read on brain cancer, heres a snippit from their half year report.
Subsequent to the half-year, the research program has been expanded to include testing the effect of both cannabidiol ('CBD') and cannabigerol ('CBG') on tumour cells when delivered via a nanoparticle delivery system. Nanoparticles are believed to improve the bioavailability and the blood to brain barrier issues, which are being optimised using SNEDD (Self Nano-Emulsifying Drug Delivery).
If successful, this would potentially lead to a significant breakthrough in the treatment of brain cancer through oral administration (rather than invasive treatments).
Cool yeah, that's why I invested for the epilepsy and other treatments. I downloaded their catalogue and the products they have in final stages of trials. Cheers
What am I supposed to be reading, the news from last year?
Spread stupid though, Good to hold see where this goes.
The futures bright the futures cannabis. My nephew died of a brain hemorrhage from epilepsy and the treatment wasn't out. All kind investors from eua donated to his funeral last year. After seeing and reviewing the research I would honestly put my money in here for the future. Not for a quick trade but for the future and I will hold until medical trials convert to fda approvals.